Labshake search

1 - 12 of 12 citations for I 309 CCL1 Human since 2019

• Structural bases for the Charcot–Marie–Tooth disease induced by single amino acid substitutions of myelin protein zero

  Masayoshi Sakakura, et al., bioRxiv - Neuroscience 2023

  Quote: ... and Wizard I & II (Rigaku) with a Protein Crystallization System 2 (PXS2 ...
• Metal ion activation and DNA recognition by the Deinococcus radiodurans manganese sensor DR2539

  Cristiano Mota, et al., bioRxiv - Biophysics 2024

  Quote: ... Wizard I&II (Rigaku reagents) and JCSG + (Molecular Dimensions) ...
• ZomB is essential for chemotaxis of Vibrio alginolyticus by the rotational direction control of the polar flagellar motor

  Norihiro Takekawa, et al., bioRxiv - Microbiology 2021

  Quote: ... Wizard Cryo I and II (Rigaku), and Crystal Screen I and II (Hampton Research) ...
• Metal ion activation and DNA recognition by the Deinococcus radiodurans manganese sensor DR2539

  Cristiano Mota, et al., bioRxiv - Biophysics 2024

  Quote: ... and Wizard I&II (Rigaku reagents). Single crystals were obtained in condition F12 (PEG 8K 30% (w/v) ...
• ATP dependent polymerization dynamics of bacterial actin proteins involved in Spiroplasma swimming

  Daichi Takahashi, et al., bioRxiv - Biophysics 2022

  Quote: ... Wizard Cryo I-II (Rigaku Reagents, Inc.), PEG/Ion Screen I-II (Hampton Research ...
• The FlhA linker mediates flagellar protein export switching during flagellar assembly

  Yumi Inoue, et al., bioRxiv - Microbiology 2020

  Quote: ... Wizard Cryo I and II (Rigaku Reagents, Inc.), Crystal Screen and Crystal Screen 2 (Hampton Research) ...
• Mycobacterial OtsA structures unveil substrate preference mechanism and allosteric regulation by 2-oxoglutarate and 2-phosphoglycerate

  Vítor Mendes, et al., bioRxiv - Biochemistry 2019

  Quote: ... Crystals were obtained in the Wizard Classic I&II screen (Rigaku), solution E10 and were flash frozen in liquid nitrogen after a brief soak in a solution containing mother liquor and 25% ethylene glycol ...
• Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase

  Ruipeng Lei, et al., bioRxiv - Microbiology 2022

  Quote: Crystallization screening was performed using the JCSG Core Suites I-IV (Rigaku) with thrombin-digested NA at 7 mg mL-1 ...
• Diversification by CofC and control by CofD govern biosynthesis and evolution of coenzyme F₄₂₀ and its derivative 3PG-F₄₂₀

  Mahmudul Hasan, et al., bioRxiv - Microbiology 2021

  Quote: ... Sitting drop crystallization trials were set up with screens Wizard I and II (Rigaku), PEG/Ion (Hampton Research) ...
• A Fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis

  Pooja Gupta, et al., bioRxiv - Biochemistry 2021

  Quote: ... An initial crystallization condition was identified I the Wizards Classic 3&4 crystallisation screen (Rigaku), well F2 (40% PEG400 ...
• Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors

  Nina M. van Sorge, et al., bioRxiv - Microbiology 2020

  Quote: ... The complex was concentrated to 9 mg/mL and screened against the commercial Wizards I/II/III/IV (Rigaku) and JCSG+ (QIAgen ...
• ATP dependent polymerization dynamics of bacterial actin proteins involved in Spiroplasma swimming

  Daichi Takahashi, et al., bioRxiv - Biophysics 2022

  Quote: Crystallisation screening was performed using the sitting-drop vapor-diffusion technique with the following screening kits: Wizard Classic I-II (Rigaku Reagents, Inc., Bainbidge Island, USA), Wizard Cryo I-II (Rigaku Reagents ...